ALAUNOS THERAPEUTICS Trademark

Trademark Overview

On Thursday, November 4, 2021, a trademark application was filed for ALAUNOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALAUNOS THERAPEUTICS trademark a serial number of 97975889. The federal status of this trademark filing is REGISTERED as of Tuesday, July 18, 2023. This trademark is owned by ZIOPHARM Oncology, Inc.. The ALAUNOS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research
alaunos therapeutics

General Information

Serial Number97975889
Word MarkALAUNOS THERAPEUTICS
Filing DateThursday, November 4, 2021
Status700 - REGISTERED
Status DateTuesday, July 18, 2023
Registration Number7117008
Registration DateTuesday, July 18, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Description of MarkThe mark consists of the word "ALAUNOS" with a thin line intersecting the "O" above the word "THERAPEUTICS".
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code042
First Use Anywhere DateMonday, January 31, 2022
First Use In Commerce DateMonday, January 31, 2022

Trademark Owner History

Party NameALAUNOS THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHouston, TX 77005
Party NameALAUNOS THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHOUSTON, TX 77054
Party NameALAUNOS THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressHOUSTON, TX 77054
Party NameZIOPHARM Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Trademark Events

Event DateEvent Description
Wednesday, August 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 19, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 15, 2022ASSIGNED TO EXAMINER
Wednesday, August 17, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 17, 2022NON-FINAL ACTION WRITTEN
Monday, August 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 31, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 31, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 31, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 31, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 19, 2023TEAS STATEMENT OF USE RECEIVED
Friday, May 19, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 19, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 19, 2023DIVISIONAL REQUEST RECEIVED
Friday, May 19, 2023SOU EXTENSION 1 FILED
Friday, May 19, 2023USE AMENDMENT FILED
Monday, June 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 12, 2023DIVISIONAL PROCESSING COMPLETE
Monday, June 12, 2023SOU EXTENSION 1 GRANTED
Monday, June 12, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 13, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 14, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, May 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 18, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

therapeutics alaunos research medical